Mirum Pharmaceuticals, Inc. (MIRM) Capital expenditures 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$954,000FY2025 · since FY2019: $281,000 → $954,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $954,000 | -3.9% |
| FY2024 | $993,000 | +811.0% |
| FY2023 | $109,000 | -60.8% |
| FY2022 | $278,000 | +1058.3% |
| FY2021 | $24,000 | -89.3% |
| FY2020 | $225,000 | -19.9% |
| FY2019 | $281,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice